Drug Trial Radar · NCT03622593
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Last checked: Nov 20, 2026Latest source record: Jul 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
951
Actual
Start
Oct 9, 2018
Primary completion
Oct 19, 2020
Study completion May 31, 2023
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Aug 9, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy, safety, and pharmacokinetics of faricimab administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME).
Conditions
- Diabetic Macular Edema
Interventions
AfliberceptDrug
Aflibercept 2 mg was administered by intravitreal (IVT) injection into the study eye once every 8 weeks (Q8W).
FaricimabDrug
Faricimab 6 mg was administered by IVT injection into the study eye either once every 8 weeks (Q8W) in arm A or according to a personalized treatment interval (PTI) in arm B.
Sham ProcedureProcedure
The sham is a procedure that mimics an IVT injection and involves the blunt end of an empty syringe (without a needle) being pressed against the anesthetized eye. It was administered to participants in all three treatments arms at applicable visits to maintain masking among treatment arms.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in BCVA in the Study Eye Averaged Over Weeks 48, 52, and 56, ITT and Treatment-Naive PopulationsTime frame: From Baseline through Week 56
Locations
188 sites in 24 countries. Site status is shown where the registry gives one.
Associated Retina Consultants
Phoenix, Arizona
Retinal Research Institute, LLC
Phoenix, Arizona
Northwest Arkansas Retina Associates
Springdale, Arkansas
California Retina Consultants
Bakersfield, California
Retina-Vitreous Associates Medical Group
Beverly Hills, California
The Retina Partners
Encino, California
Retina Consultants of Orange County
Fullerton, California
Northern California Retina Vitreous Associates
Mountain View, California
Retinal Consultants Med Group
Sacramento, California
California Retina Consultants
Santa Barbara, California
California Retina Consultants
Santa Maria, California
Bay Area Retina Associates
Walnut Creek, California
University of Colorado
Aurora, Colorado
Retina Consultants of Southern
Colorado Springs, Colorado
Retina Group of New England
Waterford, Connecticut
Retina Group of Florida
Fort Lauderdale, Florida
National Ophthalmic Research Institute
Fort Myers, Florida
Florida Eye Associates
Melbourne, Florida
Bascom Palmer Eye Institute
Palm Beach Gardens, Florida
Fort Lauderdale Eye Institute
Plantation, Florida
Retina Vitreous Assoc of FL
St. Petersburg, Florida
Southeast Retina Center
Augusta, Georgia
University Retina and Macula Associates, PC
Oak Forest, Illinois
Prairie Retina Center
Springfield, Illinois
Retina Specialists
Baltimore, Maryland
Tufts Medical Center
Boston, Massachusetts
Associated Retinal Consultants
Grand Rapids, Michigan
Vitreo-Retinal Associates
Grand Rapids, Michigan
Retina Consultants of Nevada
Las Vegas, Nevada
Envision Ocular, LLC
Bloomfield, New Jersey
Long Is. Vitreoretinal Consult
Hauppauge, New York
New York University
New York, New York
Ophthalmic Cons of Long Island
Oceanside, New York
Retina Assoc of Western NY
Rochester, New York
University of Rochester Flaum Eye Institute
Rochester, New York
The Retina Consultants
Slingerlands, New York
Cleveland Clinic Foundation
Cleveland, Ohio
Mid Atlantic Retina - Wills Eye Hospital
Philadelphia, Pennsylvania
Retina Consultants Of Carolina
Greenville, South Carolina
Charleston Neuroscience Inst
Ladson, South Carolina
Showing 40 of 188 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.